These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30791601)

  • 21. Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation.
    De Pooter CM; Scalliet PG; Elst HJ; Huybrechts JJ; Gheuens EE; Van Oosterom AT; Fichtinger-Schepman AM; De Bruijn EA
    Cancer Res; 1991 Sep; 51(17):4523-7. PubMed ID: 1873796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines.
    Mora-Lagos B; Cartas-Espinel I; Riquelme I; Parker AC; Piccolo SR; Viscarra T; Reyes ME; Zanella L; Buchegger K; Ili C; Brebi P
    PLoS One; 2020; 15(1):e0228331. PubMed ID: 31990955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Cytotoxicity and Synergistic Potential of Aspirin and Aspirin Analogues Towards Oesophageal and Colorectal Cancer.
    Kilari RS; Bashir AIJ; Devitt A; Perry CJ; Safrany ST; Nicholl ID
    Curr Clin Pharmacol; 2019; 14(2):141-151. PubMed ID: 30417794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro establishment of cis-diammine-dichloroplatinum(II) resistant lung cancer cell line and modulation of apoptotic gene expression as a mechanism of resistant phenotype.
    Yoon SS; Ahn KS; Kim SH; Shim YM; Kim J
    Lung Cancer; 2001; 33(2-3):221-8. PubMed ID: 11551417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin C enhances chemosensitization of esophageal cancer cells in vitro.
    Abdel-Latif MM; Raouf AA; Sabra K; Kelleher D; Reynolds JV
    J Chemother; 2005 Oct; 17(5):539-49. PubMed ID: 16323444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches.
    McCabe NH; Stevenson L; Scanlon E; Douglas R; Kennedy S; Keminer O; Windshügel B; Zisterer D; Kennedy RD; Blayney JK; Turkington RC
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF; Hunakova L; Kelland LR
    Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
    Zhao Y; Bao Q; Schwarz B; Zhao L; Mysliwietz J; Ellwart J; Renner A; Hirner H; Niess H; Camaj P; Angele M; Gros S; Izbicki J; Jauch KW; Nelson PJ; Bruns CJ
    Stem Cells Dev; 2014 Jan; 23(2):180-92. PubMed ID: 24021093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting cisplatin-resistant human tumor cells with metabolic inhibitors.
    Sullivan EJ; Kurtoglu M; Brenneman R; Liu H; Lampidis TJ
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):417-27. PubMed ID: 24352250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo resistance towards anthracyclines, etoposide, and cis-diamminedichloroplatinum(II).
    Seeber S; Osieka R; Schmidt CG; Achterrath W; Crooke ST
    Cancer Res; 1982 Nov; 42(11):4719-25. PubMed ID: 6889912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pSTAT3 Levels Have Divergent Expression Patterns and Associations with Survival in Squamous Cell Carcinoma and Adenocarcinoma of the Oesophagus.
    O' Sullivan KE; Michielsen AJ; O' Regan E; Cathcart MC; Moore G; Breen E; Segurado R; Reynolds JV; Lysaght J; O' Sullivan J
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes.
    Shen DW; Akiyama S; Schoenlein P; Pastan I; Gottesman MM
    Br J Cancer; 1995 Apr; 71(4):676-83. PubMed ID: 7710928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
    Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to cisplatin in an E. coli B/r NalR mutant.
    Bouayadi K; Villani G; Salles B
    Mutat Res; 1993 Jun; 294(1):77-87. PubMed ID: 7683761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in thymidylate synthase and its inhibition rate and changes in dihydropyrimidine dehydrogenase after the administration of 5-fluorouracil with cisplatin to nude mice with gastric cancer xenograft SC-1-NU.
    Sakurai Y; Uraguchi T; Imazu H; Hasegawa S; Matsubara T; Ochiai M; Funabiki T
    Gastric Cancer; 2004; 7(2):110-6. PubMed ID: 15224198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma.
    Mongan AM; Lynam-Lennon N; Doyle SL; Casey R; Carr E; Cannon A; Conroy MJ; Pidgeon GP; Brennan L; Lysaght J; Reynolds JV; O'Sullivan J
    Int J Med Sci; 2019; 16(4):519-528. PubMed ID: 31171903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells.
    Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Hu H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819864311. PubMed ID: 31405336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Viale M; Cafaggi S; Parodi B; Esposito M
    Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
    Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
    Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.